Barriers to using a nationwide skin cancer screening program: Findings from Germany
Goerig T, Schneider S, Schilling L, Diehl K (2018)
Publication Type: Journal article
Publication year: 2018
Journal
Book Volume: 41
Pages Range: 774-779
Journal Issue: 12
DOI: 10.1159/000492440
Abstract
Background: In 2008, a nationwide standardized and systematic skin cancer screening (SCS) service, which is globally unique, was implemented in Germany. We aimed to provide current data on SCS use, to explore barriers to SCS usage, and to identify population groups with lower rates of SCS use. Methods: We analyzed data from 2,635 participants (18-45 years) in the National Cancer Aid Monitoring on Sunbed Use. Data on SCS use, barriers to SCS, and sociodemographic characteristics were obtained. Chi-square tests and logistic regression analyses were performed to analyze the data. Data was weighted by age, sex, educational level, and federal state. Results: In total, 39.0% of participants reported having been screened for skin cancer at least once in their lifetime. The subjective importance of different barriers varied depending on the participants' educational level. SCS use was negatively associated with male sex (odds ratio (OR) = 0.63, p < 0.001), low level of education (OR = 0.83, not significant), immigrant background (OR = 0.63; p < 0.001), and having no employment. Conclusion: Although the SCS is part of the regular healthcare services offered in Germany, our data showed lower usage among certain population groups. Barriers relevant for these groups should be considered when developing measures to increase SCS use.
Authors with CRIS profile
Involved external institutions
Germany (DE)How to cite
APA:
Goerig, T., Schneider, S., Schilling, L., & Diehl, K. (2018). Barriers to using a nationwide skin cancer screening program: Findings from Germany. Oncology Research and Treatment, 41(12), 774-779. https://doi.org/10.1159/000492440
MLA:
Goerig, Tatiana, et al. "Barriers to using a nationwide skin cancer screening program: Findings from Germany." Oncology Research and Treatment 41.12 (2018): 774-779.
BibTeX: Download